Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Dyadic International Inc (DYAI)

NASDAQ
Currency in USD
1.687
-0.023(-1.37%)
Real-time Data
DYAI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
1.6601.735
52 wk Range
0.9262.670
Key Statistics
Edit
Prev. Close
1.71
Open
1.7
Day's Range
1.66-1.735
52 wk Range
0.926-2.67
Volume
31.92K
Average Vol. (3m)
39.3K
1-Year Change
-3.39%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DYAI Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
7.500
Upside
+344.576%
Members' Sentiments
Bearish
Bullish
ProTips
Stock has taken a big hit over the last week
Show more

Dyadic International Inc Company Profile

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial to demonstrate the safety in humans of a protein produced using the C1 platform. It has also developed the Dapibus thermophilic, a filamentous fungal-based microbial protein production platform to enable the development and large-scale manufacture of cost-effective proteins, metabolites, and other biologic products for use in non-pharmaceutical applications, including food, nutrition, and wellness. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa’s Rubic One Health; Joint Development Agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Compare DYAI to Peers and Sector

Metrics to compare
DYAI
Peers
Sector
Relationship
P/E Ratio
−8.0x−1.3x−0.7x
PEG Ratio
−0.880.060.00
Price / Book
14.8x0.9x2.6x
Price / LTM Sales
15.0x22.9x3.2x
Upside (Analyst Target)
338.6%376.2%44.5%
Fair Value Upside
Unlock11.2%6.6%Unlock

Analysts' Recommendations

1 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 7.500

(+344.58% Upside)

People Also Watch

2.710
TAIT
+0.37%
2.350
PMD
+0.86%
1.810
GEG
-0.55%
1.536
RDI
+3.80%
1.210
CLIR
+2.54%

FAQ

What Is the Dyadic (DYAI) Stock Price Today?

The Dyadic stock price today is 1.687

What Stock Exchange Does Dyadic Trade On?

Dyadic is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Dyadic?

The stock symbol for Dyadic is "DYAI."

What Is the Dyadic Market Cap?

As of today, Dyadic market cap is 50.45M.

What is Dyadic Earnings Per Share?

The Dyadic EPS is -0.217.

What Is the Next Dyadic Earnings Date?

Dyadic will release its next earnings report on Mar 26, 2025.

From a Technical Analysis Perspective, Is DYAI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.